OLFEN

This brand name is authorized in Nigeria. It is also authorized in Croatia, Estonia, Hong Kong SAR China, Lithuania, Poland, Singapore.

Active ingredients

The drug OLFEN contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-3776	Tablet	OLFEN 50 GASTRO-RESISTANT TABLETS TAB 50 mg	OLFEN 50 GASTRO-RESISTANT TABLETS DICLOFENAC SODIUM 50MG Diclofenac sodium 50mg,quinoline yellow Apr-76 Drugs Imported Products 210Packs Prescription Only Medicine (POM) 01/12/2022 OCULUS PHARMACARE LTD, 387 agege motor road mushin 17403203 valentine.ezeiru@oculuspharma-ng.com Acino Pharma AG, Birsweg 2, 4253 Liesberg, Switzerland, Switzerland	26/04/2023
04-3798	Gel	OLFEN 1% GEL GEL 10 mg 50g	45 CMS-PP-281790 OLFEN 1% GEL DICLOFENAC SODIUM Diclofenac sodium 50g, Lactic acid, diiopropyl adipate, isopropyl alcohol, sodium metabisulfite (E223), hydroxyethyl cellulose,, hydroxylpropyl cellulose, purified water Apr-98 Drugs Imported Products 50G, Over The Counter (OTC) 9/14/2022 OCULUS PHARMACARE LTD, 387 agege motor road mushin 17403203 valentine.ezeiru@oculuspharma-ng.com Sofarimex-industria Quimica e farmmaceutica, S.A. , Av. das Industrias, Alto do Colaride, 2735-213 Cacem Portugal, Portugal	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D11AX18	Diclofenac	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1012048, 1039632, 1074002, 1136382, 1136427, 1136438, 1388044, 1755525, 1792357, 1792368, 1792379, 1792380, 1792391, 1792403
HK	Department of Health Drug Office	30018, 30019, 34897, 37348, 48100
HR	Agencija za lijekove i medicinske proizvode	HR-H-313859076, HR-H-841350554
LT	Valstybinė vaistų kontrolės tarnyba	1003112, 1003114, 1003116, 1003505, 1014602, 1014603, 1014604, 1014744, 1017774, 1084781, 1092451, 1092452
NG	Registered Drug Product Database	04-3776, 04-3798, 04-9272
PL	Rejestru Produktów Leczniczych	100049300, 100049316, 100049339, 100090997, 100111630, 100198690, 100210243, 100430134, 100430140, 100454854, 100458350, 100459716, 100464889, 100465606
SG	Health Sciences Authority	03963P, 05455P